This study describes treatment patterns, low-density lipoprotein cholesterol (LDL-C) levels and healthcare resource utilization (HCRU) in the Netherlands in 2018 of patients with hypercholesterolaemia or mixed dyslipidaemia at high or very high cardiovascular (CV) risk. On current treatment 46% of patients reached their LDL-C goal according to the 2016 ESC/EAS guidelines and combinations of lipid lowering therapies are infrequently prescribed. Clinical and economic burden based on hospitalizations and GP visits revealed an unmet clinical need that was highest in patients with peripheral artery disease or polyvascular disease. This suggests that even in a country like the Netherlands where the standard of care is high, alternative strategies using add-on therapies are needed to help reduce CV risk.
To read more about the treatment patterns, LDL-C outcomes per subgroup and the HCRU, please have a look at the article (link)